Clinical Practice Session
Therapeutic Dilemmas in Glomerular Diseases
November 02, 2023 | 10:30 AM - 12:30 PM
Location: Room 204, Pennsylvania Convention Center
Session Description
This session covers selected topics in the treatment of glomerular diseases in which there is a level of uncertainty regarding appropriate therapy.
Support is provided by an educational grant from Travere Therapeutics, Inc.
Learning Objective(s)
- Summarize the use of corticosteroids in IgA nephropathy, including delayed release formulation of budesonide
- Describe appropriate use of combination cyclophosphamide and corticosteroids in primary membranous nephropathy
- Discuss appropriate therapy for steroid-resistant primary FSGS
- Explain the role of adding SGLT2 inhibitors in the treatment of primary glomerular diseases
Learning Pathway(s)
- Glomerular Diseases
Moderators
Presentations
- Appropriate Use of Glucocorticoids in IgA Nephropathy
10:30 AM - 11:00 AM
- Can Rituximab Replace the Modified Ponticelli Regimen in Membranous Nephropathy?
11:00 AM - 11:30 AM
- When Glucocorticoids Are Not Enough: Approach to Steroid-Resistant FSGS
11:30 AM - 12:00 PM
- SGLT2 Inhibitors in Primary Glomerulopathies: Is It Time?
12:00 PM - 12:30 PM